Theravance Email Format

Biotechnology ResearchCalifornia, United States51-200 Employees

Theravance Biopharma US, LLC is a biotechnology research company focused on developing medicines for specialty respiratory and neurologic diseases. Its established product, YUPELRI (revefenacin), is an inhalation therapy approved for the maintenance treatment of chronic obstructive pulmonary disease, illustrating the company’s approach to delivering treatments that address unmet patient needs. The organization operates from South San Francisco, California, with a global outlook that includes its Dublin, Ireland presence, reflecting its origins as a spin-off founded in 2014. With a staffing footprint described in general terms, the company positions itself within the biotechnology sector by pursuing internally discovered programs in addition to its FDA-approved therapy. Recent activities include participation in industry events and presentations related to YUPELRI, signaling ongoing engagement with scientific and medical communities.

Sign up for free to view info

Company overview Employee directory